Newborn Screening Market to be Worth $2.69 Billion by 2031

Newborn screening is a screening program for infants under which pre-symptomatic congenital conditions are detected so that treatment can be commenced as soon as possible to prevent or reduce the long-term consequences of the disease. These programs are usually run by the national or state governing bodies with the aim of screening all infants for a defined panel of disorders that are treatable. These tests include hearing, blood, pulse oximetry, and other similar tests and benefit the newborn to grow normally in the later stages of life.